Wells Fargo’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-52
| Closed | -$204 | – | 7333 |
|
|
2023
Q3 | $204 | Buy |
52
+31
| +148% | +$122 | ﹤0.01% | 6207 |
|
|
2023
Q2 | $68 | Buy |
21
+1
| +5% | +$3 | ﹤0.01% | 6660 |
|
|
2023
Q1 | $73 | Hold |
20
| – | – | ﹤0.01% | 6691 |
|
|
2022
Q4 | $628 | Buy |
20
+1
| +5% | +$31 | ﹤0.01% | 5993 |
|
|
2022
Q3 | $1K | Buy |
19
+10
| +111% | +$526 | ﹤0.01% | 6208 |
|
|
2022
Q2 | $0 | Sell |
9
-83
| -90% | – | ﹤0.01% | 7474 |
|
|
2022
Q1 | $6K | Sell |
92
-542
| -85% | -$35.3K | ﹤0.01% | 6091 |
|
|
2021
Q4 | $76K | Buy |
634
+632
| +31,600% | +$75.8K | ﹤0.01% | 5347 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 7367 |
|
|
2021
Q2 | $1K | Sell |
2
-2,501
| -100% | -$1.25M | ﹤0.01% | 6449 |
|
|
2021
Q1 | $535K | Buy |
2,503
+399
| +19% | +$85.3K | ﹤0.01% | 4356 |
|
|
2020
Q4 | $508K | Buy |
2,104
+280
| +15% | +$67.6K | ﹤0.01% | 4426 |
|
|
2020
Q3 | $192K | Sell |
1,824
-10
| -0.5% | -$1.05K | ﹤0.01% | 4811 |
|
|
2020
Q2 | $180K | Buy |
1,834
+1,287
| +235% | +$126K | ﹤0.01% | 4791 |
|
|
2020
Q1 | $41K | Sell |
547
-756
| -58% | -$56.7K | ﹤0.01% | 5180 |
|
|
2019
Q4 | $105K | Sell |
1,303
-120
| -8% | -$9.67K | ﹤0.01% | 5071 |
|
|
2019
Q3 | $173K | Buy |
1,423
+189
| +15% | +$23K | ﹤0.01% | 4855 |
|
|
2019
Q2 | $221K | Buy |
1,234
+676
| +121% | +$121K | ﹤0.01% | 4749 |
|
|
2019
Q1 | $89K | Buy |
558
+3
| +0.5% | +$478 | ﹤0.01% | 5085 |
|
|
2018
Q4 | $144K | Buy |
555
+514
| +1,254% | +$133K | ﹤0.01% | 4890 |
|
|
2018
Q3 | $10K | Buy |
41
+8
| +24% | +$1.95K | ﹤0.01% | 5604 |
|
|
2018
Q2 | $8K | Buy |
+33
| New | +$8K | ﹤0.01% | 5652 |
|